Usually easier to get approval in other countries
Post# of 148187
I'm still trying to remember the name of the biopharma I was invested in, in 2008-2009. They were approved in Canada and Europe but the FDA gave them the run around. March 2009 they were facing delisting at .88 and then got bought out for $5. The two bios I invested in after that killed the profit I made there (and more) and I abandoned bios until last year.